Ibogaine, Addiction, and the Bigger System We’re Not Talking About
I came across a conversation recently with an ER doctor on Instagram discussing ibogaine—an experimental substance being studied for addiction and trauma recovery.
At the same time, I’ve seen claims circulating online that it has been “approved” politically in the U.S. That isn’t exactly true. What is happening is a renewed interest in psychedelic-assisted therapies, including ibogaine, as part of research into treatment-resistant addiction and PTSD.
Ibogaine itself remains unapproved for general medical use and is considered medically high-risk, especially because of its effects on the heart. So the conversation around it is not simple—it sits somewhere between hope and caution.
But what struck me wasn’t just the drug discussion.
It was the reason people are even talking about it.
The system people are actually trying to escape or survive in
Behind all of this is a much bigger reality that doesn’t get enough attention:
Addiction is not happening in isolation.
It is tied to:
- trauma that hasn’t been processed
- lack of long-term mental health care
- unstable housing
- and a system that often cycles people in and out of short-term treatment
Even when someone is ready for help:
- there are often not enough detox or treatment beds
- waitlists are long
- and support systems are fragmented
And when people do get out of treatment, the next step is often the hardest part: 👉 going back into the same environment that contributed to the problem in the first place.
Housing is part of the treatment system—but we don’t treat it that way
One of the biggest gaps is housing.
Without stable housing:
- recovery becomes fragile
- relapse risk increases
- and people often end up in shared housing with others struggling with the same issues
This isn’t a small detail—it’s a structural problem.
We talk about treatment as if it ends at discharge, but for many people, that’s exactly where the system stops supporting them.
Why ibogaine is entering the conversation
This is where experimental treatments like ibogaine are being discussed.
Not because they are simple solutions—but because:
- current systems are overwhelmed
- conventional treatments don’t work for everyone
- and relapse rates remain high for many substances
So people start looking for alternatives that might “break the cycle.”
But ibogaine is not a solution on its own. It comes with serious medical risks and requires careful supervision. It is still experimental, and the science is evolving.
The real question underneath all of this
Maybe the more important question isn’t:
- “Is there a new drug that can fix addiction?”
But instead:
- Why are so many people cycling through trauma, treatment, and homelessness without stable recovery support in between?
Because if housing, trauma care, and long-term support were strong and stable, the urgency around experimental solutions might look very different.
Final thought
We tend to focus on substances—new treatments, new policies, new approvals.
But the deeper issue is the environment people return to after they ask for help.
Until that changes, we are always going to be treating symptoms of a much larger system.
No comments:
Post a Comment